Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Prevail Therapeutics Inc. (PRVL)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K |
| Revenues | | 100.0% |
| Cost of goods sold | | 100.0% |
| Gross profit | | 0.0% |
| Research and development | | 16237.9% |
| General and administrative | | 5381.6% |
| Depreciation | | 63.2% |
| EBIT | | -21619.5% |
| Pre-tax income | | -21939.1% |
| Income taxes | | 0.0% |
| Net income | | -21939.1% |
|